Prevention of post-operative complications by using a HMG-CoA reductase inhibitor in patients undergoing one-lung ventilation for non-cardiac surgery: study protocol ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2018-12-18

AUTHORS

Murali Shyamsundar, Cecilia O’Kane, Gavin D. Perkins, Gavin Kennedy, Christina Campbell, Ashley Agus, Glenn Phair, Danny McAuley

ABSTRACT

BackgroundPostoperative pulmonary complications (PPC) and peri-operative myocardial infarction (MI) have a significant impact on the long-term mortality of surgical patients. Patients undergoing one-lung ventilation (OLV) for surgery are at a high risk of developing these complications. These complications could be associated with intensive care unit (ICU) admissions and longer hospital stay with associated resource and economic burden. Simvastatin, a HMG-CoA reductase enzyme inhibitor has been shown to have pleiotropic anti-inflammatory effects as well as being endothelial protective. The benefits of statins have been shown in various observational studies and in small proof-of-concept studies. There is an urgent need for a well-designed, large clinical trial powered to detect clinical outcomes. The Prevention HARP 2 trial will test the hypothesis ‘simvastatin 80 mg when compared to placebo will reduce cardiac and pulmonary complications in patients undergoing elective oesophagectomy, lobectomy or pneumonectomy’.Methods/designThe Prevention HARP 2 trial is a UK multi-centre, randomised, double-blind, placebo-controlled trial. Adult patients undergoing elective oesophagectomy, lobectomy or pneumonectomy will be eligible. Patients who are already on statins will be excluded from this trial. Patients will be randomised to receive simvastatin 80 mg or matched placebo for 4 days pre surgery and for up to 7 days post surgery. The primary outcome is a composite outcome of PPC and MI within 7 days post surgery. Various secondary outcome measures including clinical outcomes, safety outcomes and health economic outcomes will be collected. The study aims to recruit 452 patients in total across 12 UK sites.DiscussionThe results of the Prevention HARP 2 trial should add to our understanding of the benefits of peri-operative statins and influence clinical decision-making. Analysis of blood and urine samples from the patients will provide insight into the mechanism of simvastatin action.Trial registrationInternational Standard Randomised Controlled Trials registry, ID: ISRCTN48095567. Registered on 11 November 2016. More... »

PAGES

690

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s13063-018-3078-5

DOI

http://dx.doi.org/10.1186/s13063-018-3078-5

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1110752701

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30563555


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Double-Blind Method", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Elective Surgical Procedures", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Esophagectomy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hydroxymethylglutaryl-CoA Reductase Inhibitors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Multicenter Studies as Topic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Myocardial Infarction", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "One-Lung Ventilation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pneumonectomy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Randomized Controlled Trials as Topic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Respiratory Distress Syndrome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Simvastatin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Time Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "United Kingdom", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Centre for Experimental Medicine, Queen\u2019s University Belfast, BT9 7BL, Belfast, UK", 
          "id": "http://www.grid.ac/institutes/grid.4777.3", 
          "name": [
            "Centre for Experimental Medicine, Queen\u2019s University Belfast, BT9 7BL, Belfast, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Shyamsundar", 
        "givenName": "Murali", 
        "id": "sg:person.01027351713.07", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01027351713.07"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centre for Experimental Medicine, Queen\u2019s University Belfast, BT9 7BL, Belfast, UK", 
          "id": "http://www.grid.ac/institutes/grid.4777.3", 
          "name": [
            "Centre for Experimental Medicine, Queen\u2019s University Belfast, BT9 7BL, Belfast, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "O\u2019Kane", 
        "givenName": "Cecilia", 
        "id": "sg:person.0706061252.72", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0706061252.72"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Warwick Trials Unit, University of Warwick, CV4 7AL, Coventry, UK", 
          "id": "http://www.grid.ac/institutes/grid.7372.1", 
          "name": [
            "Warwick Trials Unit, University of Warwick, CV4 7AL, Coventry, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Perkins", 
        "givenName": "Gavin D.", 
        "id": "sg:person.01243160227.13", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01243160227.13"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Northern Ireland Clinical Trials Unit, 1st Floor Elliott Dynes Building, Royal Hospitals, BT12 6BA, Belfast, UK", 
          "id": "http://www.grid.ac/institutes/grid.454053.3", 
          "name": [
            "Northern Ireland Clinical Trials Unit, 1st Floor Elliott Dynes Building, Royal Hospitals, BT12 6BA, Belfast, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kennedy", 
        "givenName": "Gavin", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Northern Ireland Clinical Trials Unit, 1st Floor Elliott Dynes Building, Royal Hospitals, BT12 6BA, Belfast, UK", 
          "id": "http://www.grid.ac/institutes/grid.454053.3", 
          "name": [
            "Northern Ireland Clinical Trials Unit, 1st Floor Elliott Dynes Building, Royal Hospitals, BT12 6BA, Belfast, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Campbell", 
        "givenName": "Christina", 
        "id": "sg:person.015060506150.34", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015060506150.34"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Northern Ireland Clinical Trials Unit, 1st Floor Elliott Dynes Building, Royal Hospitals, BT12 6BA, Belfast, UK", 
          "id": "http://www.grid.ac/institutes/grid.454053.3", 
          "name": [
            "Northern Ireland Clinical Trials Unit, 1st Floor Elliott Dynes Building, Royal Hospitals, BT12 6BA, Belfast, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Agus", 
        "givenName": "Ashley", 
        "id": "sg:person.010237457221.38", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010237457221.38"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Northern Ireland Clinical Trials Unit, 1st Floor Elliott Dynes Building, Royal Hospitals, BT12 6BA, Belfast, UK", 
          "id": "http://www.grid.ac/institutes/grid.454053.3", 
          "name": [
            "Northern Ireland Clinical Trials Unit, 1st Floor Elliott Dynes Building, Royal Hospitals, BT12 6BA, Belfast, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Phair", 
        "givenName": "Glenn", 
        "id": "sg:person.012452111004.14", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012452111004.14"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centre for Experimental Medicine, Queen\u2019s University Belfast, BT9 7BL, Belfast, UK", 
          "id": "http://www.grid.ac/institutes/grid.4777.3", 
          "name": [
            "Centre for Experimental Medicine, Queen\u2019s University Belfast, BT9 7BL, Belfast, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "McAuley", 
        "givenName": "Danny", 
        "id": "sg:person.016040610317.75", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016040610317.75"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s11239-012-0687-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003705177", 
          "https://doi.org/10.1007/s11239-012-0687-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00595-004-2791-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031932668", 
          "https://doi.org/10.1007/s00595-004-2791-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/cc7868", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027089853", 
          "https://doi.org/10.1186/cc7868"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11136-011-9903-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044866349", 
          "https://doi.org/10.1007/s11136-011-9903-x"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2018-12-18", 
    "datePublishedReg": "2018-12-18", 
    "description": "BackgroundPostoperative pulmonary complications (PPC) and peri-operative myocardial infarction (MI) have a significant impact on the long-term mortality of surgical patients. Patients undergoing one-lung ventilation (OLV) for surgery are at a high risk of developing these complications. These complications could be associated with intensive care unit (ICU) admissions and longer hospital stay with associated resource and economic burden. Simvastatin, a HMG-CoA reductase enzyme inhibitor has been shown to have pleiotropic anti-inflammatory effects as well as being endothelial protective. The benefits of statins have been shown in various observational studies and in small proof-of-concept studies. There is an urgent need for a well-designed, large clinical trial powered to detect clinical outcomes. The Prevention HARP 2 trial will test the hypothesis \u2018simvastatin 80 mg when compared to placebo will reduce cardiac and pulmonary complications in patients undergoing elective oesophagectomy, lobectomy or pneumonectomy\u2019.Methods/designThe Prevention HARP 2 trial is a UK multi-centre, randomised, double-blind, placebo-controlled trial. Adult patients undergoing elective oesophagectomy, lobectomy or pneumonectomy will be eligible. Patients who are already on statins will be excluded from this trial. Patients will be randomised to receive simvastatin 80\u2009mg or matched placebo for 4\u2009days pre surgery and for up to 7\u2009days post surgery. The primary outcome is a composite outcome of PPC and MI within 7\u2009days post surgery. Various secondary outcome measures including clinical outcomes, safety outcomes and health economic outcomes will be collected. The study aims to recruit 452 patients in total across 12 UK sites.DiscussionThe results of the Prevention HARP 2 trial should add to our understanding of the benefits of peri-operative statins and influence clinical decision-making. Analysis of blood and urine samples from the patients will provide insight into the mechanism of simvastatin action.Trial registrationInternational Standard Randomised Controlled Trials registry, ID: ISRCTN48095567. Registered on 11 November 2016.", 
    "genre": "article", 
    "id": "sg:pub.10.1186/s13063-018-3078-5", 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2784459", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1297400", 
        "issn": [
          "1468-6708", 
          "1745-6215"
        ], 
        "name": "Trials", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "19"
      }
    ], 
    "keywords": [
      "one-lung ventilation", 
      "days post surgery", 
      "pulmonary complications", 
      "myocardial infarction", 
      "elective oesophagectomy", 
      "clinical outcomes", 
      "post surgery", 
      "intensive care unit admission", 
      "peri-operative myocardial infarction", 
      "pleiotropic anti-inflammatory effects", 
      "UK multi-centre", 
      "care unit admission", 
      "benefits of statins", 
      "placebo-controlled trial", 
      "non-cardiac surgery", 
      "long-term mortality", 
      "Controlled Trials Registry", 
      "Secondary outcome measures", 
      "anti-inflammatory effects", 
      "post-operative complications", 
      "HMG-CoA reductase inhibitors", 
      "large clinical trials", 
      "health economic outcomes", 
      "unit admission", 
      "simvastatin 80", 
      "longer hospital", 
      "surgical patients", 
      "adult patients", 
      "composite outcome", 
      "primary outcome", 
      "analysis of blood", 
      "Trials Registry", 
      "study protocol", 
      "clinical trials", 
      "Multi-Center", 
      "observational study", 
      "outcome measures", 
      "safety outcomes", 
      "high risk", 
      "patients", 
      "complications", 
      "economic burden", 
      "surgery", 
      "enzyme inhibitors", 
      "reductase inhibitors", 
      "statins", 
      "trials", 
      "urine samples", 
      "outcomes", 
      "oesophagectomy", 
      "placebo", 
      "lobectomy", 
      "pneumonectomy", 
      "simvastatin", 
      "ventilation", 
      "concept study", 
      "simvastatin action", 
      "small proof", 
      "inhibitors", 
      "urgent need", 
      "economic outcomes", 
      "infarction", 
      "admission", 
      "registry", 
      "hospital", 
      "mortality", 
      "blood", 
      "prevention", 
      "study", 
      "burden", 
      "total", 
      "risk", 
      "benefits", 
      "days", 
      "UK sites", 
      "significant impact", 
      "protocol", 
      "action", 
      "measures", 
      "effect", 
      "hypothesis", 
      "mechanism", 
      "need", 
      "samples", 
      "sites", 
      "standards", 
      "impact", 
      "analysis", 
      "results", 
      "understanding", 
      "ID", 
      "insights", 
      "proof", 
      "resources"
    ], 
    "name": "Prevention of post-operative complications by using a HMG-CoA reductase inhibitor in patients undergoing one-lung ventilation for non-cardiac surgery: study protocol for a randomised controlled trial", 
    "pagination": "690", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1110752701"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s13063-018-3078-5"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30563555"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s13063-018-3078-5", 
      "https://app.dimensions.ai/details/publication/pub.1110752701"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-09-02T16:01", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/article/article_758.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1186/s13063-018-3078-5"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s13063-018-3078-5'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s13063-018-3078-5'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s13063-018-3078-5'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s13063-018-3078-5'


 

This table displays all metadata directly associated to this object as RDF triples.

295 TRIPLES      21 PREDICATES      140 URIs      127 LITERALS      23 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s13063-018-3078-5 schema:about N070d2fa838b34c98a4a442d09d3ca26f
2 N112555435b544694b75e5aabddb43f83
3 N1594df5c6da7427baa5c797fc25b7c83
4 N1aa99fd52c604f959c489ac05acaf804
5 N3470152614e44f4cb8aa28a9e8e9be2a
6 N3574beee97e048b988429eba0de22374
7 N5132b2a9ffb84b1a84019f3bf56c7f95
8 N576e54a06c05491cad8843d06bb1233f
9 N6b4f9c95ad634c419e71865260cf006e
10 N740bf5bed6cd4951b3350a1703377ab6
11 N9a8f067077674f34a1c688256abd32dc
12 Nbcae3076d7044794b5ab816519692ab0
13 Nc9b3b6f43508416a8c3bf459cce598bc
14 Nd5b811e970674bc586fb149bb21e6f86
15 Ne63f3f7d6bdc45b8bdcdff839d6eed68
16 Nf09b169b8c4c4b00b941fe05451a87b2
17 anzsrc-for:11
18 anzsrc-for:1102
19 anzsrc-for:1103
20 schema:author N770cab64384941ec96e13643aba1f8ab
21 schema:citation sg:pub.10.1007/s00595-004-2791-8
22 sg:pub.10.1007/s11136-011-9903-x
23 sg:pub.10.1007/s11239-012-0687-9
24 sg:pub.10.1186/cc7868
25 schema:datePublished 2018-12-18
26 schema:datePublishedReg 2018-12-18
27 schema:description BackgroundPostoperative pulmonary complications (PPC) and peri-operative myocardial infarction (MI) have a significant impact on the long-term mortality of surgical patients. Patients undergoing one-lung ventilation (OLV) for surgery are at a high risk of developing these complications. These complications could be associated with intensive care unit (ICU) admissions and longer hospital stay with associated resource and economic burden. Simvastatin, a HMG-CoA reductase enzyme inhibitor has been shown to have pleiotropic anti-inflammatory effects as well as being endothelial protective. The benefits of statins have been shown in various observational studies and in small proof-of-concept studies. There is an urgent need for a well-designed, large clinical trial powered to detect clinical outcomes. The Prevention HARP 2 trial will test the hypothesis ‘simvastatin 80 mg when compared to placebo will reduce cardiac and pulmonary complications in patients undergoing elective oesophagectomy, lobectomy or pneumonectomy’.Methods/designThe Prevention HARP 2 trial is a UK multi-centre, randomised, double-blind, placebo-controlled trial. Adult patients undergoing elective oesophagectomy, lobectomy or pneumonectomy will be eligible. Patients who are already on statins will be excluded from this trial. Patients will be randomised to receive simvastatin 80 mg or matched placebo for 4 days pre surgery and for up to 7 days post surgery. The primary outcome is a composite outcome of PPC and MI within 7 days post surgery. Various secondary outcome measures including clinical outcomes, safety outcomes and health economic outcomes will be collected. The study aims to recruit 452 patients in total across 12 UK sites.DiscussionThe results of the Prevention HARP 2 trial should add to our understanding of the benefits of peri-operative statins and influence clinical decision-making. Analysis of blood and urine samples from the patients will provide insight into the mechanism of simvastatin action.Trial registrationInternational Standard Randomised Controlled Trials registry, ID: ISRCTN48095567. Registered on 11 November 2016.
28 schema:genre article
29 schema:isAccessibleForFree true
30 schema:isPartOf N83b131c8c782473183fe8bf632fa9e80
31 N9db1705347b24246823d2205c272a01f
32 sg:journal.1297400
33 schema:keywords Controlled Trials Registry
34 HMG-CoA reductase inhibitors
35 ID
36 Multi-Center
37 Secondary outcome measures
38 Trials Registry
39 UK multi-centre
40 UK sites
41 action
42 admission
43 adult patients
44 analysis
45 analysis of blood
46 anti-inflammatory effects
47 benefits
48 benefits of statins
49 blood
50 burden
51 care unit admission
52 clinical outcomes
53 clinical trials
54 complications
55 composite outcome
56 concept study
57 days
58 days post surgery
59 economic burden
60 economic outcomes
61 effect
62 elective oesophagectomy
63 enzyme inhibitors
64 health economic outcomes
65 high risk
66 hospital
67 hypothesis
68 impact
69 infarction
70 inhibitors
71 insights
72 intensive care unit admission
73 large clinical trials
74 lobectomy
75 long-term mortality
76 longer hospital
77 measures
78 mechanism
79 mortality
80 myocardial infarction
81 need
82 non-cardiac surgery
83 observational study
84 oesophagectomy
85 one-lung ventilation
86 outcome measures
87 outcomes
88 patients
89 peri-operative myocardial infarction
90 placebo
91 placebo-controlled trial
92 pleiotropic anti-inflammatory effects
93 pneumonectomy
94 post surgery
95 post-operative complications
96 prevention
97 primary outcome
98 proof
99 protocol
100 pulmonary complications
101 reductase inhibitors
102 registry
103 resources
104 results
105 risk
106 safety outcomes
107 samples
108 significant impact
109 simvastatin
110 simvastatin 80
111 simvastatin action
112 sites
113 small proof
114 standards
115 statins
116 study
117 study protocol
118 surgery
119 surgical patients
120 total
121 trials
122 understanding
123 unit admission
124 urgent need
125 urine samples
126 ventilation
127 schema:name Prevention of post-operative complications by using a HMG-CoA reductase inhibitor in patients undergoing one-lung ventilation for non-cardiac surgery: study protocol for a randomised controlled trial
128 schema:pagination 690
129 schema:productId N10dcb6c6d1ad4b74892874af4b22ecae
130 N505312b1086542a99a9b074d90a11249
131 Ncf50a2ef0d604b66965fbf0d5bacbcef
132 schema:sameAs https://app.dimensions.ai/details/publication/pub.1110752701
133 https://doi.org/10.1186/s13063-018-3078-5
134 schema:sdDatePublished 2022-09-02T16:01
135 schema:sdLicense https://scigraph.springernature.com/explorer/license/
136 schema:sdPublisher N838a38eb10d04bb6aa167dd4528ca807
137 schema:url https://doi.org/10.1186/s13063-018-3078-5
138 sgo:license sg:explorer/license/
139 sgo:sdDataset articles
140 rdf:type schema:ScholarlyArticle
141 N070d2fa838b34c98a4a442d09d3ca26f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Multicenter Studies as Topic
143 rdf:type schema:DefinedTerm
144 N10dcb6c6d1ad4b74892874af4b22ecae schema:name pubmed_id
145 schema:value 30563555
146 rdf:type schema:PropertyValue
147 N112555435b544694b75e5aabddb43f83 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Humans
149 rdf:type schema:DefinedTerm
150 N1594df5c6da7427baa5c797fc25b7c83 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Respiratory Distress Syndrome
152 rdf:type schema:DefinedTerm
153 N1aa99fd52c604f959c489ac05acaf804 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name United Kingdom
155 rdf:type schema:DefinedTerm
156 N3470152614e44f4cb8aa28a9e8e9be2a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Risk Factors
158 rdf:type schema:DefinedTerm
159 N3574beee97e048b988429eba0de22374 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
160 schema:name Pneumonectomy
161 rdf:type schema:DefinedTerm
162 N505312b1086542a99a9b074d90a11249 schema:name dimensions_id
163 schema:value pub.1110752701
164 rdf:type schema:PropertyValue
165 N5132b2a9ffb84b1a84019f3bf56c7f95 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
166 schema:name One-Lung Ventilation
167 rdf:type schema:DefinedTerm
168 N53724b3a2ec9407793d62b7d48c63649 rdf:first sg:person.0706061252.72
169 rdf:rest N853a024cfdfe4dfebeeda44666aea416
170 N576e54a06c05491cad8843d06bb1233f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
171 schema:name Hydroxymethylglutaryl-CoA Reductase Inhibitors
172 rdf:type schema:DefinedTerm
173 N60b1ca79ae9e4eff816ec38887b8f741 rdf:first sg:person.015060506150.34
174 rdf:rest Nc66cb7bf84bc47b5b887fcdddcef0f03
175 N6b4f9c95ad634c419e71865260cf006e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
176 schema:name Treatment Outcome
177 rdf:type schema:DefinedTerm
178 N740bf5bed6cd4951b3350a1703377ab6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
179 schema:name Simvastatin
180 rdf:type schema:DefinedTerm
181 N770cab64384941ec96e13643aba1f8ab rdf:first sg:person.01027351713.07
182 rdf:rest N53724b3a2ec9407793d62b7d48c63649
183 N77d02eda8afb473f8e5ee229fe1958ab rdf:first Na9499767a5db497eb268091f16cd6610
184 rdf:rest N60b1ca79ae9e4eff816ec38887b8f741
185 N838a38eb10d04bb6aa167dd4528ca807 schema:name Springer Nature - SN SciGraph project
186 rdf:type schema:Organization
187 N83b131c8c782473183fe8bf632fa9e80 schema:volumeNumber 19
188 rdf:type schema:PublicationVolume
189 N853a024cfdfe4dfebeeda44666aea416 rdf:first sg:person.01243160227.13
190 rdf:rest N77d02eda8afb473f8e5ee229fe1958ab
191 N8700fd838b6b4694b414cb5f04d18fa5 rdf:first sg:person.016040610317.75
192 rdf:rest rdf:nil
193 N9a8f067077674f34a1c688256abd32dc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
194 schema:name Esophagectomy
195 rdf:type schema:DefinedTerm
196 N9db1705347b24246823d2205c272a01f schema:issueNumber 1
197 rdf:type schema:PublicationIssue
198 Na9499767a5db497eb268091f16cd6610 schema:affiliation grid-institutes:grid.454053.3
199 schema:familyName Kennedy
200 schema:givenName Gavin
201 rdf:type schema:Person
202 Nbcae3076d7044794b5ab816519692ab0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
203 schema:name Time Factors
204 rdf:type schema:DefinedTerm
205 Nc5a42e66e92246328acce940fb3741ff rdf:first sg:person.012452111004.14
206 rdf:rest N8700fd838b6b4694b414cb5f04d18fa5
207 Nc66cb7bf84bc47b5b887fcdddcef0f03 rdf:first sg:person.010237457221.38
208 rdf:rest Nc5a42e66e92246328acce940fb3741ff
209 Nc9b3b6f43508416a8c3bf459cce598bc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
210 schema:name Double-Blind Method
211 rdf:type schema:DefinedTerm
212 Ncf50a2ef0d604b66965fbf0d5bacbcef schema:name doi
213 schema:value 10.1186/s13063-018-3078-5
214 rdf:type schema:PropertyValue
215 Nd5b811e970674bc586fb149bb21e6f86 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
216 schema:name Myocardial Infarction
217 rdf:type schema:DefinedTerm
218 Ne63f3f7d6bdc45b8bdcdff839d6eed68 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
219 schema:name Randomized Controlled Trials as Topic
220 rdf:type schema:DefinedTerm
221 Nf09b169b8c4c4b00b941fe05451a87b2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
222 schema:name Elective Surgical Procedures
223 rdf:type schema:DefinedTerm
224 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
225 schema:name Medical and Health Sciences
226 rdf:type schema:DefinedTerm
227 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
228 schema:name Cardiorespiratory Medicine and Haematology
229 rdf:type schema:DefinedTerm
230 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
231 schema:name Clinical Sciences
232 rdf:type schema:DefinedTerm
233 sg:grant.2784459 http://pending.schema.org/fundedItem sg:pub.10.1186/s13063-018-3078-5
234 rdf:type schema:MonetaryGrant
235 sg:journal.1297400 schema:issn 1468-6708
236 1745-6215
237 schema:name Trials
238 schema:publisher Springer Nature
239 rdf:type schema:Periodical
240 sg:person.010237457221.38 schema:affiliation grid-institutes:grid.454053.3
241 schema:familyName Agus
242 schema:givenName Ashley
243 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010237457221.38
244 rdf:type schema:Person
245 sg:person.01027351713.07 schema:affiliation grid-institutes:grid.4777.3
246 schema:familyName Shyamsundar
247 schema:givenName Murali
248 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01027351713.07
249 rdf:type schema:Person
250 sg:person.01243160227.13 schema:affiliation grid-institutes:grid.7372.1
251 schema:familyName Perkins
252 schema:givenName Gavin D.
253 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01243160227.13
254 rdf:type schema:Person
255 sg:person.012452111004.14 schema:affiliation grid-institutes:grid.454053.3
256 schema:familyName Phair
257 schema:givenName Glenn
258 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012452111004.14
259 rdf:type schema:Person
260 sg:person.015060506150.34 schema:affiliation grid-institutes:grid.454053.3
261 schema:familyName Campbell
262 schema:givenName Christina
263 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015060506150.34
264 rdf:type schema:Person
265 sg:person.016040610317.75 schema:affiliation grid-institutes:grid.4777.3
266 schema:familyName McAuley
267 schema:givenName Danny
268 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016040610317.75
269 rdf:type schema:Person
270 sg:person.0706061252.72 schema:affiliation grid-institutes:grid.4777.3
271 schema:familyName O’Kane
272 schema:givenName Cecilia
273 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0706061252.72
274 rdf:type schema:Person
275 sg:pub.10.1007/s00595-004-2791-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031932668
276 https://doi.org/10.1007/s00595-004-2791-8
277 rdf:type schema:CreativeWork
278 sg:pub.10.1007/s11136-011-9903-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1044866349
279 https://doi.org/10.1007/s11136-011-9903-x
280 rdf:type schema:CreativeWork
281 sg:pub.10.1007/s11239-012-0687-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003705177
282 https://doi.org/10.1007/s11239-012-0687-9
283 rdf:type schema:CreativeWork
284 sg:pub.10.1186/cc7868 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027089853
285 https://doi.org/10.1186/cc7868
286 rdf:type schema:CreativeWork
287 grid-institutes:grid.454053.3 schema:alternateName Northern Ireland Clinical Trials Unit, 1st Floor Elliott Dynes Building, Royal Hospitals, BT12 6BA, Belfast, UK
288 schema:name Northern Ireland Clinical Trials Unit, 1st Floor Elliott Dynes Building, Royal Hospitals, BT12 6BA, Belfast, UK
289 rdf:type schema:Organization
290 grid-institutes:grid.4777.3 schema:alternateName Centre for Experimental Medicine, Queen’s University Belfast, BT9 7BL, Belfast, UK
291 schema:name Centre for Experimental Medicine, Queen’s University Belfast, BT9 7BL, Belfast, UK
292 rdf:type schema:Organization
293 grid-institutes:grid.7372.1 schema:alternateName Warwick Trials Unit, University of Warwick, CV4 7AL, Coventry, UK
294 schema:name Warwick Trials Unit, University of Warwick, CV4 7AL, Coventry, UK
295 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...